Concepedia
Free Radical Biology and Medicine · 2021 · 10 citations · 7 references
Life SciencesBiochemistryOncologyCell SignalingMolecular OncologySignal TransductionCancer GlycobiologyGlycan SignalingGlycosylation PathwaysPediatric LymphomasAdvanced Glycation End ProductsHodgkin Lymphoma TherapyLate ComplicationsLate-onset Complications
7
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
Changyong Lu, John Cijiang He, Weijing Cai et al. · Proceedings of the National Academy of Sciences · 2004 · 228 citations · Full text
Medicine, Endocrinology, Immunology +17
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone de Vries, Michael Schaapveld, Cécile P.M. Janus et al. · JNCI Journal of the National Cancer Institute · 2020 · 98 citations · Full text
Social Sciences, Oncology, Cancer Epidemiology +12
Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling
Xian Deng, Wei Huang, Juan Peng et al. · Inflammation · 2017 · 98 citations
Life Sciences, Cell Biology, Immunology +14
Long-term administration of advanced glycation end-product stimulates the activation of NLRP3 inflammasome and sparking the development of renal injury
Wan-Ju Yeh, Hsin‐Yi Yang, Man‐Hui Pai et al. · The Journal of Nutritional Biochemistry · 2016 · 55 citations
Medicine, Nephrology, Pathobiology +16
Accelerated atherosclerosis, hyperlipoproteinemia and insulin resistance in long-term survivors of Hodgkin lymphoma during childhood and adolescence
Michaela Čepelová, Jarmila Kruseová, Aleš Lukš et al. · Neoplasma · 2019 · 23 citations · Full text
Medicine, Cardiology, Endocrinology +16